Curriculum Vitae€¦ · (IPER), Pune, Maharastra, India. Institute of Pharmaceutical Education...

1

Curriculum Vitae

Dr. R.SUTHAKARAN M.Pharm., Ph.D., DPMM., DPQCQAM, DCA.

F.No.505, Ajitha Towers,

Road No.4/1 Haripuri Colony,

R.K.Puram, Kothapet, Hyderabad-500035.

Andhra Pradesh, India

Mobile: 91-9440394053, 91-9704511195

E-mail: [email protected]

ACADEMIC CHRONICLES

Year Degree Institution / University Class

2005 - 2010 PhD SASTRA University,

ADDITIONAL QUALIFICATIONS

Year Degree Institution / University

1997 D.P.Q.C.Q.A.M.

1996-1997 D.P.M.M.

Institute of Pharmaceutical Education Research

(IPER), Pune, Maharastra, India.

Institute of Pharmaceutical Education Research

(IPER), Pune, Maharastra, India.

PhD Thesis Title:

“Synthesis and Pharmacological Investigations of Some New 4(3H)-Quinazolinone

analogs and QSAR, CADD studies”

(Pharmaceutical Chemistry) Tanjavur, Tamil Nadu, India.

1998 - 2000

M.Pharm.

(Pharmaceutical Chemistry)

K.M,College of Pharmacy, Madurai,

MGR Medical University,

I

Chennai,Tamil Nadu, India

1993 - 1997

B.Pharm.

A.K. College of Pharmacy, Madurai,

MGR Medical University,

I

Chennai,Tamil Nadu, India

mailto:[email protected]

2

WORKING EXPERIENCES

07-12-2015 to till date Working as Principal and Professor. Vijaya College of

Pharmacy, Hyderabad, Andhra Pradesh, India.

05-07-2013 to 05-12-2015 . Principal and Professor, Teegala Ram Reddy College of


03-07-2013 to 04-07-2013 Worked as Principal and Professor, Vijaya College of Pharmacy,

Hyderabad, Andhra Pradesh, India.

9-10-2010 to 02-07-2013 Principal and Professor, Teegala Ram Reddy College of


2008-2010

14-7-2009 to 8-10-2010

Principalv& Professor Smt. Sarojini Ramulamma College of

Pharmacy, Mahabubnagar, Andhra Pradesh, India.

2007-2008

4-7-2007 to 4-7-2009

Principal (In-charge) & Asso.Professor Vijaya College of


2005 – 2007

15-6-2005 to 1-7--2007

Assistant Professor in S.N. Vanitha Pharmacy Mahavidyalaya,


2001 -2005

12-10-2001 to 13-6-2005

Assistant Professor in Smt. Sarojini Ramulamma College of


2000-2001

3-1-2000 to 3-10-2001

Assistant Professor in Fathima College of Pharmacy,

Kadayanallur, Tamil Nadu, India.

1997-1998

13-08-1997 to 13-08-1998 Lecturer in N.M.S. College of Pharmacy, Tamil Nadu, India.

3

WORKING EXPERIENCES

3)07-12-2015 to till date

2) 03-07-2013 to 04-07-

Working as Principal and Professor. Vijaya College of

2013 Pharmacy, Hyderabad, Andhra Pradesh, India.

1) 4-7-2007 to 4-7-

2009

2) 05-07-2013 to 05-

Principal and Professor, Teegala Ram Reddy College of


12-2015

1) 9-10-2010 to 02-

07-2013

2) 14-7-2009 to 8-10-

2010 Principal & Professor Smt. Sarojini Ramulamma College of

1) 12-10-2001 to 13-


6-2005

15-6-2005 to 1-7--2007 Assistant Professor in S.N. Vanitha Pharmacy Mahavidyalaya,


3-1-2000 to 3-10-2001 Assistant Professor in Fathima College of Pharmacy,

Kadayanallur, Tamil Nadu, India.

13-08-1997 to 13-08-1998 Lecturer in N.M.S. College of Pharmacy, Tamil Nadu, India.

ACREDITATIONS

*Recognized and Ratified as Professor, Asst.Professor by the Staff Selection Committee

of Osmania University, Hyderabad, Andra Pradesh, India.

*Recognized and Ratified as Asso. Professor by the Staff Selection Committee of J.N.T,

University, Hyderabad, Andra Pradesh, India.

*PhD Evaluator in Karpakam University

4

1) Convener- Two day national level DST- SEMINAR GRAND 50000 SERB?F/7993/2015

Dt,16/02/2016 on Industrial chemistry and Green chemistry

2) *DST- NRDMS project worth 1000000 as a Principal Investigator

Project Title

Risk Analysis of Encephalitis Disease in Khammam District (Telangana State) and Geospatial

Approach for Surveillance

File No: - NRDMS/01/176/2016

Natural Resources Data Management System

3) Co-convener – One day national level DST- SEMINAR GRAND 50000 –Impact of

biopharmaceutical engineering and its applications on human health on 16/03/2018

Testimonials /Seminars/Conferences/Symposium/Journal Referee/Thesis evaluator/Guide

S.No Particulars No.

1. Seminars and presented papers 200

2 Conferences 35

3 Workshops 07

4 Quality improvement programme (QIP) 02

5 Journal referee 02

6 Examiners 07 Universities

7 Question paper setting 02 Universities

8 B.Pharm thesis evaluator 05 universities

9 M.Pharm thesis evaluator 05 universities

10 PhD thesis evaluator 02 universities

11 B.Pharm guide 02 groups

12 M.Pharm guide 40 members

13 PhD guide 04 members in 04 universities

14 Membership 02 Life member

15 Industrial trips 04

16 Grant to AICTE Applied

17 Grant to ICMR Applied

5

18 Grant to DST 4) SEMINAR GRAND

50000

SERB?F/7993/2015

Dt,16/02/2016

2)DST- NRDMS project

worth 1000000 as a

Principal Investigator

Project Title Risk

Analysisof

Encephalitis Disease in

Khammam District

(TelanganaState)and

Geospatial Approach for

Surveillance

File No: -

NRDMS/01/176/2016

Natural Resources Data

Management System

19 Industrial collaborations 02

20 Foreign university collaborations Applied

21 IPC-2018 Elocution competition Judge

23/11/2018 at Sri indu Institute of pharmacy-

Hyderabad

RESEARCH PUBLICATIONS

National 120

International

Presentations 200

List of articles in – PAPER

PUBLICATIONS

6

1. R.Suthakaran, Gopinath, SSrikanth, S.B. Muthu et al. Analytical profile of raw material

and finished product of cefuroxime axetil. Int J of Research and development in

pharmacy and life sciences. 2013; 2(2):371-376. ISSN: 2278-0238.

2. Sudha parimala, V. Hemanthkumar, S.M Shantha kumar, R.Suthakaran, A. Tamil selvan.

Analgesic and CNS depressant activity of methanoic extract of Cissus vitegenia and

Cissus pallida. Int J of research and development in pharmacy and life sciences. 2013;

2(2):330-332. ISSN: 2278-0238

3. R.Suthakaran. Legal protection of intellectual property rights. Int. J of pharmacy.

2013;3(4):835-836. ISSN: 2249-1848.

4. Naga malleswra rao, K.Venkata kumar,C. Madhuri kommoju , R.suthakaran et al.

Tandem mass spectrometric method for the quantitative determination of pioglitazone

and their metabolites in human plasma by using liquid-liquid extraction technique and its

application to pharmacokinetic studies. American J of Pharmtech research.

2013;3(4):314-330. ISSN: 2249-3387.

5. KVM Krishna, Raju manda, R.suthakaran. Formulation and evaluation of antidiabetic

herbal extract preparation. JPR online.BIOMED RX 2013;1(5): 555-557.

6. R,Suthakaran. Regulatory requirements for generic drug product in Japan. World journal

of pharmacy and pharmaceutical sciences. 2013; 2(5):XXX. ISSN: 2278-4357.

7. R,Suthakaran, srikanth, kshemada kappagantu, A,tamil selvan, S.B muthu vadivel.

Synthesis and invitro evaluation of novel urea derivatives as ACE inhibitors. JPR online.

2013;1(1): 24-31.

8. R,Suthakaran. Regulatory process involved in generic drug approval process in USA,

Europe and India. Indo American J of Pharm Res. 2013; 3(12):1451-1456.ISSN: 2231-

6876.

9. R.Suthakaran. comparative study of regularory requirements for the approval of generic

drugs for association of south east asian nation (ASEAN), Gulf co-operative council

(GCC) and united states food and drug administration (USFDA). JPR online. 2014;8(1):

59-63.

10. R.Suthakaran. the assessment of current regulatory guidelines for biosimilar- A flobal

scenario. JPR online. 2014;8(1):49-52.

11. R Suthakaran, K.Rajesh, K.sunil kumar, P.manasa. Comparative profiles of

neuromuscular blocking properties of leaves and seeds of plant vicia faba. Int J of

Innovative pharmaceutical sciences and research. 2014;2(1):535-541.ISSN: 2347-2154.

12. D.V.R.N. Bikshapathi, V.Durga madhuri, V.V. Rajesham, R.suthakaran. preparation and

evaluation of Fast dissolving oral film containing naratriptan Hcl. American J of pharm

tech research. 2014;4(2): 799-812. ISSN: 2249-3387.

13. K.sunil kumar, R.suthakaran, K.rajesh, B.K.Jayalakshmi. gastroprotective activity of

celosia argentea leaves against stress induced ulcers in rats. World J of Pharm Res. 2014;

3(2):2709-2715. ISSN: 2277-7105.

7

14. R,suthakaran, chaitanya Prasad K, prabodh.M, Ashish S. concept of 505(b)(2)

Applicationn: Benefits and challenges. Int J of Drug regulatory affairs. 2014;2(2):16-20.

ISSN: 2321-6794.

15. R,suthakaran, chaitanya Prasad K, prabodh.M, Ashish S, naveen reddy M. exclusivity

strategies of innovator drug developers. Int J of drug regulatory affairs. 2014;2(2):21-25.

ISSN: 2321-6794.

16. R,suthakaran, chaitanya Prasad K, prabodh.M, Ashish S, Abhijit K. Indonesian patent

system: An overview. Int J of Drug regulatory affairs. 2014;2(2):26-30. ISSN: 2321-

6794.

17. R,suthakaran, chaitanya Prasad K, prabodh.M, Ashish S. An overview of Iranian patent

system. Asian J of pharm tech and Innovation. 2014;2(6):1-7. ISSN: 2347-8810.

18. Chaitanya Prasad Kolla*1, Prabodh M1, Rastrapal D1, Suthakaran R1 , The Purview of

Regulatory Affairs in the Pharmaceutical Industry, Asian Journal of Pharmaceutical

Technology & Innovation, 02 (06); 2014; 01-06, ISSN: 2347-8810

19. Nadipineni AK. Dileep KG, Ravindra CK, Suthakaran R. An overview of Chinese drug

regulatory system: A review. Int J Of drug regulatory affairs. 2014; 2(3):14-18. ISSN:

2321-6794.

20. Raju.M, Virajaj kaya, B.Sreedevi, R,sai santhosh, R.suthakaran. design and invitro

evaluation of non erodible polymeric matrix tablets of Isoniazid using sintering

technique. World J of Pharm.Res. 2014;3(7):507-515. ISSN: 2277-7105.

21. Raju.M, Virajaj kaya, B.Sreedevi, R. Navya, R.suthakaran. Design, fabrication and

evaluation of drug release kinetics from Metformin HCl sustained release matrix tablets

by using natural gums. World J of Pharm.Res. 2014; 3(7):499-506. ISSN: 2277-7105.

22. Raju.M, Virajaj kaya, B.Sreedevi, B.Kusuma Pravallika, R.suthakaran. Non-ionic

surfactant based vesicle Niosome as a potential ocular drug delivery system. World J of

Pharm.Res. 2014;3(11):XXX. ISSN: 2278-4357.

23. Raju.M, Virajaj kaya, B.Sreedevi, T.H. Fathima, R.suthakaran. Niosome: An unique drug

delivery system. World J of Pharm.Res. 2014;3(11):XXX. ISSN: 2278-4357.

24. Chaitanya Prasad, R,suthakaran. New drug development and various drug applications

under FDA. Emerging trends in drug discovery. AICADD-2014.

25. K.sunil kumar, K,rajesh, D.anusha, r.suthakaran. potentiation of phenobarbitone induced

hypnosis by celosia argentea leaves. Int J of medicine and Pharm.Res. 2014;2(3):591-

594. ISSN: 2321-2624.

26. P.deepika, R.suthakaran. validated RP-HPLC method as a tool for the estimation of

tinidazole in pharmaceutical dosage forms. Int J of research and development in

pharmacy and life sciences. 2014;3(4):1089-1092. ISSN: 2278-0238.

27. Chaitanya Prasad, prabodh M, Rastrapal D, Suthakaran R. The purview of regualatory

affairs in the pharmaceutival industry. Asian J of pharm tech and Innovation.

2014;2(6):1-6. ISSN: 2347-8810.

8

28. Chaitanya Prasad, Prabodh M, Rastrapal D, Suthakaran R.prescription drug user fee act

and its influence on review time and budget. J of pharamacreations. 2014;1(2):41-46.

29. P.raghavendra, G.veena, N.sangeetha, Srivennela, R.Suthakaran. Microwave synthesis

and anti-inflammatory evaluation of some new imidazolo quinoline analaogs.

2011;4(1):91-102. ISSN: 0974-1496.

30. P.Raghavendra, G.veena, Srivennela, R.Suthakaran et al. synthesis, antioxidant and

antimicrobial study of novel imidazolo-quinoline derivatives. International journal of

chemical and analytical sciences, 2011;2(6):62-69. ISSN: 0976-1206.

31. C.H.Sridevi,K.Balaji, A.Naidu R.Suthakaran. synthesis of some phenyl

pyrazolobenzimidazoloquinoxaline derivatives as potent antihistaminic agents. E-J

Chem.2010;7(1):234-238.

32. Shashank D, Vishwanath T, Balasubramaniam V, Suthakaran R. synthesis of some

substituted benzothiazole derivatives and its biological activities. Int J of Pharmtech

Res.2009; 1(4):1224. ISSN: 0974-4304.

33. G.Tuljarani, D.Gowrishankar, P.Kadgapathi, R,Suthakaran. Viswible spectrophotometric

determination of Rosuvastatin in bulk and pharmaceutical formulations. Oriental J of

chemistry. 2010; 6(2):589-593. ISSN: 2231-5039.

34. R.Suthakaran A.Tamil selvan, Ravali and S.Prithvi. Effect of Piper methysticum root on

CNS activity. Journal of Pharmacy and Phytotherapeutics. 2013;1(4): 1-4. ISSN:

35. R.Suthakaran A.Tamil selvan, R.P.Ashwini, B.Jayalaxmi and M.Viswanath.

Bioevaluation of Sirupeelai samoolam herbal formulation for Antiurolithiatic activity.,

International Journal of Research in Pharmacology & Pharmacotherapeutics. 2013;2(2):

1-6. ISSN: 2278-2656.

36. A.Tamilselvan, R.Suthakaran et al. Phytochemical and Pharmacological validation of the

polyherbal extract on rodents. International Journal of Medical Sciences and

Biotechnology. 2013; 1(2): 23-29.

37. Phytochemical, Pharmacognostical and Pharmacological evaluation of polyherbal

extract, I(II), sept2013, 33-40. International Journal of Medical Sciences and

Biotechnology.

38. A.Tamilselvan, R.Suthakaran et al. Phytochemical evaluation and Anti inflammatory

activity of Boswellia ovalifoliolata. International Journal of Pharmaceutical Sciences

Review and Research.2013; 22(1): 148-151.

39. R.Suthakaran A.Tamil selvan, S.Ramya sree, S.R.Navya sree, Mohammed ehtesham

uddin, KVM Krishna, , Application of immunosuppressant cyclophosphamide in the

9

treatment of systemic lupus erythematosus , world journal of pharmacy and

pharmaceutical sciences,2013 volume 2, issue 4, 1695-1698. ISSN: 2278-4357.

40. R.Suthakaran A. Tamil Selvan, Gutha Girisha, Vijaybhaskar, , Comparative evaluation of

newer topical antifungal agents in the treatment of superficial fungal infections (Tinea or

Dermatophytic), Int. Res. J. Pharm. 2013, 4 (X).

41. Suthakaran R, KVM Krishna, Raju Manda ,Formulation and Evaluation of Anti diabetic

Herbal Extract Preparation, BioMedRx 2013,1(5),555-557 .

42. R. Suthakaran Sudha Parimala, V.Hemanth Kumar, S.M.Shanta Kumar, A.Tamil Selvan,

In vitro anti diabetic and anti oxidant activity of methanolic extracts of Cissus pallida and

Cissus vitegenia, BioMedRx 2013, 1(4), 374-376.

43. Suthakaran, Sudha Parimala, V. Hemanth Kumar, S. M. Shanta Kumar, A. Tamil Selvan,

In vivo antidiabetic activty of Cissus pallida and Cissus vitegenia, BioMedRx 2013,1(5),469-

472.

44. R. Suthakaran A.Tamil Selvan, C. Jothibaskara Mohan, S. Karpagam Kumara Sundari,

Study on Role of Postmarketing Surveillance in New Drug Development, Asian J.

Management 4(1): Jan-Mar. 2013,12-15.

45. R. Suthakaran Anuradhabai Sandala,, Aparna Vema, A. Ravindernath, K. S. K. Rao

Patnaik, Molecular properties prediction, Docking studies, and synthesis of 5-benzimidazole-

1-yl- methyl –[1,3,4] oxadiazole-2-thiol and their derivatives. Intl. J. Res. Dev. Pharm. L.

Sci, 2(3), 2013,432-438.ISSN: 2278-0238.

46. R. Suthakaran, Srikanth, Kshemada Kappagantu, A. Tamil Selvan, S. B. Muthu Vadivel,

Synthesis and in vitro evaluation of novel urea derivatives as ACE inhibitors, BioMedRx

Vol.1 2013, 1(1),24-31.

47. R.Suthakaran, C.Krishna veni, S.Subramanyam, S.Raja, T.Srivalli, N.Sowmya sri,

S.Srikanth. Synthesis, Characterization and Antimicrobial Screening of 1-Suubstituted-3-

methyl-4-arylhydrazino-2-pyrazolin-5-ones and Isooxazolines. Int. J. Inno. Pharm. Res.

2011, 2(3), 156-60. ISSN: 0976-4607.

48. R.Suthakaran, P.Siddartha Kumar,S.Subramanyam, S.Raja, T.Srivalli, K.Yamini

.Synthesis, Characterization and pharmacological screening of 3-[5-substituted-1,3-

oxadiazole-2-yl]-2- methyl quinazoline-4(3H)-ones. Intl. Journal of Innovative

Pharmaceutical research, 2011,2(4) ,166-171.

10

49. R.Suthakaran, P.Raghavendra, G.Veena, G.Arun Kumar, E.Raj Kumar, N.Sangeetha,

B.Sirivennela, S.Smarani, H.Praneeth Kumar. Synthesis, Antioxidant and Antimicrobial

study of Novel Imidazolo Quinazoline Derivatives. Int.J.Chem.Anal. Sci. 2011; 2(6): 62-9.

ISSN: 0976-1209.

50. R.Suthakaran, M. Sailendra, S.Subramanyam, S.Raja, K.Yamini. Design of new

rivastigmine analogs based on molecular docking and binding free energy calculations- J.

Pharmacy Research-


B.Sirivennela, S.Smarani, H.Praneeth Kumar. Microwave synthesis and anti-inflammatory

evaluation of some new imidazolo quinoline analogs. Ras.J.Chem.2011; 4(1): 91-102. ISSN:

0974-1496.

52. R.Suthakaran P. Bharath Rathna Kumar, S.Subramaniyan and K.Yamini. Synthesis of

some novel 1-H pyrazole derivatives and their antibacterial activity studies. Ras.J.Chem.

2011; 4(2): 400-4. ISSN: 0974-1496.

53. .R.Suthakaran, G.Nagarajan, V.Balasumramaniam,K.Suganthi and G.Velrajan. Synthesis

and antimicrobial activity of 8-(Methylene-2”, 3”-disubstituted benzoqu inazolo-4-one)-9,2-

(4‟)-disub stituted benzopyrano pyrazoles. Indian J.Hetero Chem. 2005; 14: 201-4. ISSN:

0971-1627.

54. .R.Suthakaran, G.Nagarajan, V.Balasumramaniam, K.Suganthi, M. Marikannan, and.

G.Velrajan. Synthesis and Antitumor Activity of 4‟-aryl/alkyl-2”- D-aldosugar Disubstituted

bis-imidazole derivatives. Indian J. Hetero Chem. 2005; 15:173-6. ISSN: 0971-1627.

55. R.Suthakaran, G.Somasekhar, Ch.Sridevi,M. Marikannan, K.Suganthi and G.Nagarajan.

Synthesis of Anti-inflammatory, Antioxidant and Antibacterial activity of 7-Methoxy

benzofuran pyrazoline derivatives. Asian J Chem. 2007; 19(5): 3353-62. ISSN: 0970-7077.

56. .R.Suthakaran, S.Kavimani and D.Venkappayya, Synthesis Anti-inflammatory and

antioxidant activity of 3 - (2-(4z) - 4 - substituted benzylidene-4, 5-dihydro-5-oxo-2-phenyl

imidazol-1-yl) ethyl)-6, 8- un / dibromo subtituted-2-substituted quinazoline-(3H)-one,

Int.J.Pharmco.Bio.Sci. 2008; 2(2):29-36. ISSN: 0973-6808.

11

57. R.Suthakaran, k. Balaji, A. Naidu Ch,sridevi, Antimicrobial Evaluation and Synthesis of

Some Phenylpyrazolo benzothiazolo quinoxaline Derivatives, E-J.Chem.,2009, 6(3), 866-

870. ISSN: 0973-4945

58. Chaitanya Prasad K*, Prabodh M , Ashish S, Suthakaran R, Concept of 505 (b) (2)

application: benefits and challenges, international journal of drug regulatory affairs; 2014,

2(2), 16 – 20 issn: 2321 - 6794

59. R.Suthakaran, S.Kavimani, D.Venkappayya, A.Naidu, K.Balaji and Ch.Sridevi ,

Synthesis and biological evaluation of some indoquinaxaline pyrazolines., Ras. J. Chem.

2008; 1(2): 306-314. ISSN: 0974-1496.

60. R.Suthakaran, S.Kavimani,D.Venkappayya, Farhat sakina and K.Suganthi, Inflammation:

Synthesis and pharmacological investigation of some new 4(3H)-quinazolone Analogs as

antioxidant, antihistaminic, anti-inflammatory and antitumor agents. Ras. J. Chem. 2008;

1(2): 263-275. ISSN: 0974-1496.

61. R.Suthakaran, M.Bhagavan raju S.Kavimani,D.Venkappayya, Rajesh kumar,Ch.Sridevi,

C.Ratnamani and K.Suganthi. Synthesis, antioxidant, anti-inflammatory, antimicrobial

activities of 2-[(5-substituted aryl-1-„-N-substituted aryl amino methyl)prrazol-3-yl]

benzofuran. Ras. J. Chem. 2008; 1(1): 39-45. ISSN: 0974-1496.

62. R.Suthakran, S.Kavimani,D.Venkappayya, P.Jayasree, V.Deepthi, Fouzia Tehseen and

K.Suganthi. Microwave Assisted rapid synthesis and antimicrobial activity of 4-

oxothiozolidene derivatives. Ras. J. Chem. 2008; 1(1): 30-38. ISSN: 0974-1496.

63. R.Suthakaran, S.Kavimani ,D.Venkappayya and K.Suganthi, Synthesis and Anti-

microbial activity of 3 - (2-(4z) - 4 - substituted benzylidene-4, 5-dihydro-5-oxo-2-phenyl

imidazol-1-yl) ethyl)-6, 8- un / dibromo subtituted-2-substituted quinazoline-(3H)-one,

Ras.J.Chem 2008;2(2):29-36.ISSN: 0973-6808.

64. .R.Suthakaran, K.Balaji , A.Naidu and Ch.Sridevi. Synthesis of some phenyl pyrazolo

benzimidazolo quinoxaline derivatives. Int. J. PharmTech Res. 2009; 1(3): 816-21. ISSN:

0974-4304.

12

65. R.Suthakaran, K.Balaji and Ch.Sridevi, Antimicrobial Evaluation and Synthesis of Some

Phenylpyrazolo benzothiazolo quinaxaline derivatives, E-J. Chem., 2009; 6(3): 866-70.

ISSN: 0973-4945.

66. R.Suthakaran, K.Balaji , A.Naidu and Ch.Sridevi, Antioxidant and antiinflammatory

activity of some phenylpyrazolo benzimidazolo quinoxaline derivatives, J.Pharm

Res.2009;2(9):1370-2. ISSN: 0974-6943.

67. R.Suthakaran, K.Balaji and Ch.Sridevi, Antioxidant, antiinflammatory and

Antihistaminic activities of some Phenylpyrazolo benzothiazolo quinoxaline Derivatives, Int.

J. Chem. Sci., 2009; 7(2): 1117-26. ISSN: 0972-768

68. R.Suthakaran, K.Balaji , A.Naidu and Ch.Sridevi. Synthesis of some phenyl pyrazolo

benzimidazolo quinoxaline derivatives Oriental J.Chem. 2009; 25(2):325-8. ISSN: 2231-

5039.

69. R.Suthakaran, S.Kannan,S.Aravinth vijay Jesuraj, E.Sam Jeeva Kumar, K.Saminathan,

M.Ravikumar and B.Parimala Devi, Wound healing activity of Mimosa pudica Linn

formulation. Int. J. PharmTech Res. 2009; 1(4): 1554-58. ISSN: 0974-4304.

70. R.Suthakaran, Sudha parimala,Ch.Shashidhar, Ch.Sridevi,and V.Jyothi,

Antiinflammatory activity of Celastrus paniculat.us seeds,Int. J. PharmTech Res. 2009; 1(4):

1326-9. ISSN: 0974-4304.

71. R.Suthakaran, V.Balasubramaniam, D.Shashank, T.Viswanath, Arif Pasha, V.Nagendra,

P.Perumal, Synthesis and Characterization of benzothiazole derivatives, Int. J. ChemTech

Res. 2009; 1(4): 1224-1231. ISSN: 0974-4290.

72. R.Suthakaran,K.Balaji,A.Naidu and Ch.Sridevi, Antioxidant and antiinflammatory

activity of some phenylpyrazolo benzimidazolo quinoxaline derivatives. E-J. Chem.,

2010; 7(1): 234-38. ISSN: 0974-6943.

73. R.Suthakaran, K.Balaji , A.Naidu and Ch.Sridevi. Synthesis of some phenyl pyrazolo

benzimidazolo quinoxaline derivatives as a potent antimicrobial agents. J.Chem.Pharm.Sci.

2010; 1(3): 13-6. 0974-4304.

13

74. R.Suthakaran, D.Shashank V.Balasubramaniam, ,E. Naveen kumar, V.Sriram,

V.Padmini, T.Lathasri, Synthesis and Characterization of benzothiazole derivatives, Int. J.

Appl. Chem., 2010; 6(2): 169-75. ISSN: 0973-1792.

75. R.Suthakaran, G.Tuljarani, D.Gowri Sankar, P.Kadgapathi, and B. Satyanarayana,

Visible spectrophotometric methods for the determination of drotaverine hydrochloride in

bulk and pharmaceutical formulations., Int.J.PharmTech. Res. 2010; 2(3): 1787-91. ISSN:

0974-4304.

76. R.Suthakaran,G.Tuljarani, D.Gowri Sankar, P.Kadgapathi, and B.Satyanarayana.

Formulations Quantitative Determination of Bisoprolol Fumarate in Bulk and Pharmaceutical

Dosage Forms by Spectrophotometry. International Journal of Chemical Sciences-2010;

6(2): 169-75.ISSN: 0972-768X (5)

77. R.Suthakaran, G.Tuljarani, D.Gowri Sankar, P.Kadgapathi, and B. Satyanarayana.,

Visible Spectrophotometric Determination of Rosvastatin in Bulk and Pharmaceutical

formulations. Oriental J. Chem. 2010; 26(2): 589-93.ISSN: 2231-5039.

78. R.Suthakaran, G.Tuljarani, D.Gowri Sankar, P.Kadgapathi, and B. Satyanarayana.,

Quantitative determination of bisoprolol fumarate in bulk and pharmaceutical dosage forms

by spectrophotometry. Intl.J.Chem.Sci , 2010,8(4),2253-2258, ISSN: 0972-768X.


B.Sirivennela, S.Smarani, H.Praneeth Kumar. Microwave synthesis and anti-inflammatory

evaluation of some new imidazolo quinoline analogs. Ras. J. Chem. 2011; 4(1):91-102.ISSN:

0974-1496.

80. R.Suthakaran. The assessment of current regulatory guidelines for biosimilars-A global

scenario. JPR online. 2014; 8(1): 49-52. ISSN: 0974-6943.

81. Ch. Srinivas reddy, G.Babu, R,Suthakaran et al. formulation and evaluation of esopiclone

film coated immediate release tablets by direct compression method was published in

International organization of scientific Research. ISSN: 2250-3021. (Accepted)

14

82. Ch. Srinivas reddy, G.Babu, Kusuma pravalikka, R.Suthakaran et al. Formulation and

evaluation of Rifampicin fast dissolving tablet was published in World J of Pharmacy and

Pharmaceutical Sciences. ISSN: 2278-4357. (Accepted)

83. Ch. Srinivas reddy, G.Babu, Kusuma pravalikka, R.Suthakaran et al. Formulation and In-

vitro evaluation of Lansoprazole Colon targeted drug delivery system. World J of

Pharmaceutical research. ISSN: 2277-7105. (Accepted)

84. Ch. Srinivas reddy, G.Babu, R,Suthakaran. Phytochemical and Pharmacological

Investigations of Cardiospermim halicacabum and Gymnema sylsvestre. World J of

Pharmacy and Pharmaceutical sciences. ISSN: 2278-4357. (Accepted)

85. Raju manda, R.suthakaran et al. Formulation and evaluation of bilayered tablets of

loperamide Hcl and Simethicone. International J of Pharmaceutical science and Research.

2014; 3(10): 204-208. ISSN: 0975-8232.

86. A.Tamilselvan, R.Suthakaran et al. purgative activity of caesalpinia pulcherrima sw

leaves extracts. Research J of pharmacology and pharmacodynamics. 2013; 5(3): 164-165.

87. A.Tamilselvan, R.Suthakaran et al. Gastroprotective activity of Tephrosia purpurea.

International J Res Ayurveda Pharm. 2013; 4(5): 1-5.

88. A.Tamilselvan, R.Suthakaran et al.antiurolithiatic activity of triphala karpa chooranam. J

Adv Pharm Edu and Res. 2013; 3(3): 267-272.

89. A.Tamilselvan, R.Suthakaran et al. Role of copyright in the protection of design. Int J

pharm Sci Rev Res. 2013; 22(2): 331-332.

90. A.Tamilselvan, R.Suthakaran , Anxiolytic effect of medicago sativa seeds extract on

rodents. Indo American journal of pharmaceutical sciences. 2014; 4(1): 406-415.

91. Raju manda, R.suthakaran et al. formulation of herbal hydrogels for wound healing

activity by using vitis vinifera seeds extract. Indo American journal of pharmaceutical

research. 2014; 4(10): 3940-3944. ISSN: ISSN: 2231-6876

15

92. Raju manda, R.suthakaran et al. Design, fabrication and invitro evaluation of irbesartan

and simavastatin bilayered tablets. Journal of pharma research. 2014; 3(10): 198-203. ISSN:

2319-5622.

93. Raju manda, R.Suthakaran .Design and invitro evaluation of colon targeted oral matrix

tablets of mesalamine for the treatment of inflammatory bowel diseases. Indo American

journal of pharmaceutical research. 2014; 4(10): 3929-3934. ISSN: 2231-6876.

94. Raju manda, R.suthakaran et al. Design and invitro evaluation of transdermal drug

delivery system for aspirin. Journal of pharma research. 2014; 3(10): 194-197. ISSN: 2319-

5622.

95. Raju manda, R.suthakaran et al. Refinement of solubility of poorly water soluble drug

celecoxib by employing solid dispersion technique. Journal of scientific research in

pharmacy. 2014; 3(4): 131-134. ISSN: 2277-9469.

96. Gandla kumaraswamy, R.suthakaran et al. Simultaneous estimation of sertraline and

alprazolam in its bulk and pharmaceutical dosage form by RP_HPLC method. World journal

of pharmacy and pharmaceutical sciences. 2014;3(11): 1005-1014. ISSN: 2278-4357.

97. Gandla kumaraswamy, R.suthakaran et al. development and validation of RP-HPLC

method for simultaneous estimation of irbesartan and simvastatin in tablet dosage form.

American J of Pharmacy and health research. 2014; 2(10): 200-205.ISSN: 2321-3647.

98. B. Himaja, Vijusha M. and R. Suthakaran ,Hepatoprotective activity of different extracts

of aerial parts of limnophilla indica by using CCl4 induced model. Der Pharmacia Lettre,

2014, 6 (5):78-83. ISSN: 0975-5071.

99. K. Veeresh, V. Manasa, Vijusha M. and R. Suthakaran .Antidiarrhoeal activity of

methanolic extract of justica procumbens by castor oil and enterpooling induced methods in

rats. Scholars research library. Der Pharmacia Lettre, 2014, 6 (5):121-129. ISSN: 0975-5071.

100. M. Mamatha, V. Manasa, M. Vijusha*, R. Suthakaran Hepatoprotective activity

of methanolic leaves extract of rostellularia procumbens by using CCl4 intoxicated rats.

16

International Journal of Basic & Clinical Pharmacology, November-December 2014 ; 3(6):

964-969. ISSN: 2219-2003.

101. Dr. R. Suthakaran*, J.Baloji Naik, International journal of pharmacy, 2016,

Method Development and Validation for Simultaneous Estimation of Citicoline and

Piracetam by RP-HPLC in Bulk and Combined Dosage forms.ISSN: 2249-1848 (accepted)

102. Dr. R. Suthakaran* World journal of pharmaceutical research, 2015, volume 5,

Issue 1, 322-336. BRICS- An Emerging Nations And Its Recent Pharmaceutical Outlook

(2015) . ISSN:2277-7105

103. R. Suthakaran* World journal of pharmaceutical research, 2015, volume 5, Issue

1, 277-291. EMA AND FDA -Adaptive Clinical Trials Design . ISSN:2277-7105

104. R. Suthakaran* world journal of pharmaceutical research, 2015, volume 5, Issue

1, 656-676, Method Development And Validation For Simultaneous Estimation Of

Esomeprazole And Domperidone By RP-HPLC In Bulk And Combined Dosage Forms.

ISSN:2277-7105

105. R.Parthibarajan*, J.Anuradha, T.Hurmath Fathima and R.Suthakaran;

Formulation And Evaluation Of Transdermal Gel Of Hyoscine Hydrochloride. world journal

of pharmacy and pharmaceutical sciences, 2015, volume 5, Issue, 1178-1200. ISSN:2277-

7105.

106. Kumaraswamy. Gandla*, R. Suthakaran, Sadhana. Bommakanti, R. Lalitha. Asian

J. Pharm. Ana. 2015; Vol. 5: Issue 3, 115-118 Development and Validation of RP-HPLC

Method for Simultaneous Estimation of Albendazole and Praziqantel in Tablet Dosage Form.

ISSN:2231-5667.

107. T. Srinivasa Rao*, S. Kavimani, S. Sudhakaran, P. Veeresh Babu International

Journal of Phytopharmacology. 6(4), 2015, 235-245. Ameliorative Role Of

Hypocholesterolemic Drugs In High Fat Diet Induced Amnesia In Rats .ISSN:0975-9328.

17

108. T. Srinivasa Rao*, S. Kavimani, S. Sudhakaran, P. Veeresh Babu ; International

Journal of Biological & Pharmaceutical Research. 2015; 6(12): 991-1000. Nootropic Effect

Of Hypocholesterolemic Drugs In Scopolamine Induced Amnesic Rats .ISSN:0976-3651.

109. R.Suthakaran, Evaluation of safety and efficacy of fixed dose combination of

telmisartan 20mg and amlodipine besylate with atenolol/amlodipine combination for the

treatment of essential hypertension. World journal of pharmaceutical research

.2016;5(2):54-71. ISSN:2277-7105.

110 R. Suthakaran, Kadiri Sunil Kumar, CH. Mamatha, N. Deepika, B. Sai Sushma,

Effects of Dietary Food Ingredients on Recognition Memory by using

Object Recognition Test in Mice, Research Journal of Pharmacology and Pharmacodynamics.

9(2): April-June, 2017, ISSN 0975-4407

111 R. Suthakaran , Parthibarajan, M. Vineela bhargavi, Raju manda, Drug policies, guidelines,

acts and regulations in republic of south africa , journal of Pharma research

Vol. 6, issue 3, 2017 ISSN: 2319-5622

112 Evaluation of analgesic potential of Boerhavia diffusa roots in albino mice

Kadiri Sunil Kumar, V. Saideepthi, Shaik Shahajeb, M. Nandini, R.Suthakaran, Research

Journal of Pharmacognosy and Phytochemistry. 9(2): April- June, 2017.

113 R. Suthakaran , Kumanan, M. Ramesh, SK. Jaffar, Raju manda, Journal of Scientific

Research in Pharmacy, vol. 6, issue 3, 2017 ISSN: 2277-9469, Preclinical and clinical trial

regulations in INDIA, USA and Europe

114. Suthakaran R ,Sudheer Kumar Dokuparthi, Md Amer Khan, Anusha A, Mashma Bee,

Shaibaz, Shaik Shahajeb, Sunil Kumar K, Acute oral toxicity study of Tectona grandis Linn.

methanolic seed extract in albino mice The Journal of Phytopharmacology 2017; 6(3): 183-185

18

115 R. Suthakaran *, Parthibarajan , K. Vanaja, Raju Manda, Risks and Opportunities in

development of new drug and question based review of regulatory compliance . Journal of

Pharma Research ,Vol. 6, Issue 3, 2017 ISSN: 2319-5622

116 R.Suthakaran *, Raju.Manda, K.Sunil Kumar, M.Ramesh and K.AparnaICH guidelines of

manufacturing and quality assurance of drugs and Cosmetics, Int. J. of Pharmacy and Analytical

Research Vol-6(4) 2017 [605-617]

117 R. Suthakaran, Kadiri Sunil Kumar*, S. Mounica, Rajesh Behera, K. Vijay Kumar,

Y. Shanmukh Sai, Cognitive Enhancing Effect of Murraya koengii Leaves by Radial Arm

Maze Test in Rats Research Journal of Pharmacology and Pharmacodynamics. 8(2): April -June,

2016

118 R.Suthakaran *, DVRN Bikshapathi , M.Ramesh , T. Ramya Sree ,Raju Manda,

Drug approval process and safety recall procedures in therapeutic goods administration

Australia, Pharmacreations | Vol.4 | Issue 4 | Oct- Dec - 2017 1-13

119 Suthakaran R et al / Int. J. of Pharmacy and Analytical Research Vol-6(4) 2017 [635-644]

Regulatory affairs on health Canada

120 Suthakaran R Kadiri Sunil Kumar*, Aneesha Unnisa, K. Sai Sushmitha, Ashish Lokhande

Antidepressant Activity of Cardamom oil by Marble Burying test in rats, Der Pharmacia

Lettre, 2016, 8 (3):279-282

121 R. Suthakaran1,Sujatha Banavath*1, Ragya Eslavath1, Ch. Yella Reddy1, , J. Shiva1, U.

Ramakrishna1 and Goli. Venkateshwarlu1, FORMULATION DEVELOPMENT AND

EVALUATION OF RIZATRIPTAN BENZOATE ORAL DISINTEGRATING TABLETS,

World Journal of Pharmaceutical Research ,Volume 7, Issue 16, 1897-1906. ISSN 2277– 7105

122 CH. Shankar1, D.V.R.N. Bhikshapathi2, R. Suthakaran3, CH. Pavani Padmaja4, Amtul

Wahab5 Development and validation of RP-HPLC method for ritonavir in bulk and

pharamceutical dosage forms , Int. J. of Pharmacy and Analytical Research , |Vol.7 |

Issue 2 | Apr - Jun -2018

123 Shriya N*, Jyothi V , Suthakaran Raj, Shankar CH, Bhikshapathi D.V.R.N., Recent Approaches of Impurity

Profiling In Pharmaceutical Analysis ,Journal of Innovation in Pharmaceutical Sciences (2018);2(1): 37-44

19

124 Shankar CH*, Suthakaran R and Prem Kumar B, A New RP-HPLC Method Development and Validation for the

Simultaneous Estimation of Febuxostat And Ketorolac in Bulk and Tablet Dosage Form

Int J Biomed Investig; Vol: 1; Issue 2 ,2018

125 Suthakaran R*1, Bikshapathi DVRN1 and Suthaparimala2 ,

RP HPLC Method Development and Validation for Quantitative Estimation of Tiotropium Bromide and Oldaterol ,

Int J Biomed Investig; Vol: 1; Issue 1,2018

126 Suthakaran R1*, Shankar CH1 and Sudha Parimala2, A New analytical method development and validation of

Ambroxol, Montelukast and Levocetirizine in Tablet dosage form by RP-HPLC method ,

Int J Biomed Investig; Vol: 1; Issue 1,2018

127 ) Suthakaran R et.al., Formulation development and invitro evaluation of zolmitriptan mouth dissolving tablets ,

world journal of advance healthcare research volume 2, issue 5. 2018

128) Suthakaran R et.al Formulation development and evaluation of candesartan cilexetil immediate release tablets ,

world journal of pharmacy and pharmaceutical sciences ,sjif impact factor 7.421 volume 7, issue 10, 1382-1392

research article issn 2278 – 4357

129) Suthakaran R et.al Formulation and in vitro evaluation of gastro retentive floating tablets of glipizide , world journal

of pharmaceutical and medical research, , 2018,4(10), 139-145,

130) Suthakaran R et.al Method development and validation for simultaneous determination of isoniaizid and atazanavir

in pure and pharmaceutical formulation by using HPLC, Asian journal of pharmaceutical analysis. 8(4): october -

december, 2018

131 ) Suthakaran R, el.al., Invitro wash- off comparission studies of metronidazole mucoadhesive microspheres using

different polymers , european journal of pharmaceutical And medical research,

ejpmr, 2018,5(9), 474-477

132) R. Suthakaran et al., A Review on Pyrones, Pyrone derivatives and their biological activity, volume 8, issue

2,2019,442-450, World journal of pharmacy and pharmaceutical sciences,

133) R. Suthakaran et al., A new validated RP-HPLC method for determination of ciprofloxacin and ornidazole in bulk

pharmaceutical dosage forms. European journal of biomedical and pharmaceutical sciences. 2019

volume: 6 issue: 2 year: 2019, 386-392.

Publications Under process Pharmaceutical

analysis

20

1 ASSAY METHOD DEVELOPMENT AND MINIVALIDATION OF LINAGLIPTIN AND METFORMIN IN IMMEDIATE

RELEASE TABLETS

2 METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS DETERMINATION

OF ISONIAIZID AND

ATAZANAVIR IN PURE AND PHARMACEUTICAL FORMULATION BY USING HPLC 3 A SIMPLE RP – HPLC METHOD DEVELOPMENT AND VALIDATION OF IBUPROFEN AND TRAMADOL IN

PHARMACEUTICAL DOSAGE FORM

4 A NEW RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANEOUS

ESTIMATION OF

FEBUXOSTAT AND KETOROLAC IN BULK AND TABLET DOSAGE FORM

5 Method development and validation for the simultaneous stimulation of trifloperezine and isopeopamide in

tablet dosage form by RP HPLC

6 DEVELOPMENTANDVALIDATION OFASIMPLEANDRAPIDRPHPLCMETHODFORTHE ESTIMATIONOFNEVIRAPINEIN

BULKDRUGANDTABLET DOSAGEFORM

7 A NEW ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF AMBROXOL,MONTELUKAST AND

LEVOCETRIZINE IN TABLET DOSAGE FORM BY USING RP-HPLC METHOD

8 ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF ATAZANAVIR SULFATE CAPSULES BY RP-HPLC

9 RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF

LOSARTAN

POTASSIUM AND AMLODIPINE BESYLATE IN TABLET DOSAGE FORM

10 METHOD DEVELOPMENT AND VALIDATION of etodolac and thiocolchicoside in combiined

tablet dosage form by RP HPLC

11 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF

AMBROXOL AND DESLORATADINE

12 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF KETOROLAC TROMETHAMINE AND MOXIFLOXACIN HCl

analytical method development and validation for cilnidipine and metoprolol succinate in

pharmaceutical formulation and biorelevant dissolution media by chromatographic tecnique

13 ANALYTICALMETHOD DEVELOPMENT AND VALIDATION OF

ATENOLOL&CHLORTHALIDONWITHITSKNO

WNANDUNKNOWN IMPURITIES BY FORCED DEGRADATION STUDY IN ITS SOLID DOSAGE

FORM BY RP-HPLc

14 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF

IBUPROFEN AND PSEUDOEPHEDRINE

15 A VALIDATED RP-HPLC METHOD FOR ESTIMATION OF TELMISARTAN AND METOPROLOL

IN ITS BULK FORM

16 ANALYTICAL METHOD DEVELOPMENT AND VALIDATION FOR NIMESULIDE AND

RACEMETHIONINE IN

COMBINE DOSAGE FORM BY RP-HPLC

17 Reverse Phase High performance Liquid Chromatography method for Simultaneous

estimation of Esitalopram and Flupentixol in pure and marketed formulation.

18 METHOD DEVELOPMENT AND VALIDATION FOR THE SIMULTANIOUS ESTIMATION OF

TIOTROPIUM BROMIDE AND OLODATEROL BY USING RP HPLC

19IMULTANEOUS ESTIMATION OF CLINIDIPINE AND CHLORTHALIDONE BY RP-HPLC

SPECTRUM INDEX BASED STABILITY INDICATING METHOD DEVELOPMENT AND

VALIDATION

FOR DETERMINATION OF VARIOUS PROTON PUMP INHIBITORS AND DOMPERIDONE ….BY

HPLC

20 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF NEVIRAPINE IN BULK AND

TABLET FORMULATION

METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION OF

LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE IN PHARMACEUTICAL

FORMULATION AND BIORELEVANT DISSOLUTION MEDIA BY CHROMATOGRAPHIC TEC

Pharmaceutical regulatory affairs

19

20

21 CURRENT REGULATIONS FOR CLINICAL TRIALS FOR USA AND INDIA

interrelation between regulatory affairs,quality control and quality assurance for

regulatory submission as per ICH guidelines

22 cGMP regulations and ANDA filing process for USFDA

23 PRINCIPLES OF REGULATORY COMPLAINCE AND ROLE OF REGULATORY AFFAIRS IN HEALTH CANADA

24 MARKET PRINCIPLE OFREGULATORY COMPLIANCE (PRC)AND ROLEOFREGULATORYAFFIRSONHEALTHCANADA

25 LATEST TRENDS IN REGULATORY COMPLIANCE TRAINING AND DRUG APPROVAL IN MEDSAFE, NEW ZEALAND

26 current trends in liaison with regulatory authorities and EU DMF

27 CURRENT TRENDS IN REGULATORY PROJECT MANAGEMENT AND REGULATORY DOSSIER OF TOP TEN COMPANIES

28 PHARMACOPOEIAL STANDARDS FOR API & IND, NDA, ANDA APPROVAL PROCESS DURING 2010-2015 FROM USA

29 IND, NDA, ANDA APPROVAL PROCESS DURING 2010-2015 FROM USA

30 Product registration strategies, patent filing to India&USA

31 Product registration strategies, patent filing to India, USA & EU. Current appraisal procedures for

new regulations, standards, policies and guidance issued by Regulatory authorities by India, USA and EU

32 current regulations for various filing for the quality audits, registered products of JAPAn , SOUTH KOREA and CHINA

PROPOSAL FOR REDUCE (RT) OR SKIP TESTING (ST) AT IN-PROCESS SPECIFICATION BASED ON

ANNUAL PRODUCT REVIEW (APR)

33REGULATORY ASPECTS OF CONTRACT MANUFACTURING AND GMP REGULATIONS IN INDIA, USA AND BRAZIL

34 Electronic common technical documentation data submission to USFDA and INDIA

35 REGULATORY ISSUES FOR IMPORT, EXPORT AND DRUG APPROVAL OF LATIN AMERICAN COUNTRIES

COMMERCIALASPECTSOFREGULATORYAPPROVALSAND REGULATIONSING8COUNTRIES

LIST OF SEMINARS AND CONFERENCE

PAPER PRESENTATIONS

1. PRESENTED A PAPER IN WORLD CONFERENCE ON DISASTER

MANAGEMENT INFRASTRUCTURE AND CONTROL SYSTEMS DMIC 10-12

NOVEMBER 2003, HYDERABAD.

21

2. PRESENTED A PAPER IN NATIONAL WORKSHOP ON CLEANER

TECHNOLOGIES FOR SUSTAINABLE DEVELOPMENT HELD AT INSTITUTE OF

SCIENCE AND TECHNOLOGY JNTU ON 27TH -28TH SEPTEMBER 2005,

TWO DAY NATIONAL SMEINAR ON EMERGING TRENDS IN THE SYNTHEITC

ASPECTS OF MEDICINAL CHEMISTRY 28-29TH OCT 2005 UCPS, KAKATIYA

UNIVERSITY WARANGAL

3. Preliminary phytochemical investigation and antibacterial activity of bark and leaves of

Barrigtonia actntangal linn.

4. Synthesis and biological evaluation of some novel benzofuran pyrazoles.

5. Pharmacological evaluation of single and mixture drugs for antidiabetic activity.

UGC SPONSORED NATIONAL CONFERENCE ON CURRENT RESEARCH TRENDS

AND DEVELOPMENTS IN HETERO CYUCLIC CHEMISTRY 17, 18 MARCH 2006.

6. Synthesis and biological evaluation of some novel 2,3 disubstituted 1,3 quinazoline 4

one.

7. Design synthesis, anti-inflammatory and antimicrobial activity of 2-2 di substituted

methyulene 3,5 di phenyl pyrazoline 1 phenyl 2 acetyl 3 methyl pyrazoline 5 one.

8. Antidiabetic – a comparative studies with mixture and single drugs

INDIAN PHARMACY GRADUATES ASSOCIATION 23RD ANNUAL CONFERENCE

(4TH AND 5TH NOVEMBER 2006, CHENNAI). THEME: GLOBAL TRENDS IN PHARMA

OPPORTUNITIES AND CHALLENGES.

9. Poster presentation on PPC31. Synthesis of anti-inflammatory, antioxidant and

antibacterial activity of 7-methoxy benzofuran pyrazoline derivatives.

10. Poster presentation on synthesis and screening of anticonvulsant and antitubucular

activity of new 2-((methylene substituted amino)-3-(o-dicholorphenyl)4-amino

triazine))6,8 dibromo 3H quinazoline -4-one derivatives.

UGC CELL-OU AND TEQIP SPONSORED NATIONAL SYMPOPSIUM ON CHEMISTRY

TECHNOLOGY INTERFACE A SYNERGISTIC APPROACH 30TH SEP 1,2ND OCT 2007.

11. Novel synthesis and antitumor activity of 7 hydroxyl 4 methyl coumarin derivatives

12. Chemopthrapy in the elderly phearmacologic considerations

13. Synthesis and neuro pharmacological activity of some quinoxaline derivatives.

14. Rheumatic fever and its management

15. Recent advancement in novel drug therapy system.

22

16. WON A SECOND PRICE IN POSTER DAY-I IN AURORA‟S TECHNOLOGICAL

AND RESEARCH INSTITUTE ON AERO BIO NANO 2007 HELD AT 29TH AND

30TH MARCH2007.

17. PRESENTED A PAPER IN 9TH NATIONAL CONFERENCE ON ASSOCIATION

FOR PREVENTION AND CONTROL OF RABIES IN INDIA (APCRI) ON JULY

2007.

18. PRESENTED A POSTER IN NATIONAL SYMPOSIUM ON CHEMISTRY

TECHNOLOGY INTERFACE: “A SYNERGISTIC APPROACH” HELD AT NIZAM

COLLEGE OF TECHNOLOGY, O.U, HYDERABAD ON 30TH SEPTEMBER -2ND

OCTOBER 2007.

19. PRESENTED A POSTER IN 60th IPC NEW DELHI ON ANTICARCINOGENIC

ACTIVITY AN ANTIMICROBIAL ACTIVITY OF MOMORDICA FROSVENORI ON

DECE 12 TO 14TH 2008.

AICTE SPONSORED NATIONAL LEVEL SEMINAR ON APPLICATIONS OF

BIOSTATISTICS IN PHARMACEUTICAL SCIENCES ON AUG 16-17 2009 ORGANISED

BY JAYAMUKHI COLLEGE OF PHARMACY,NARSAMPET, WARANGAL.

20. Phytochemical and pharmacological review of Ageratum conyzoides.

21. QSAR analysis on α-carboline as antitumor agent

22. Wound healing activity of the leaf extracts and deoxyelephantopin isolated from

Elephantopus scaber linn.

23. Antitumor activity of biflavonoides from Ouratea and Luxemburgia on human cancer cell

lines.

24. Antitumor studies with extracts of Calotropis procera root employing HEP2 cells and

their possible mechanisms of action.

25. Pharmacokinetics of one daily in busulfan as part of pretransplantation preparative

regimens: a comparison with an every 6 hour dosing schedule.

26. Organosilicon containing thiazole derivatives as potential lipoxygenase inhibitors and

antiinflammatory agents.

27. Convenient synthesis of 1-substituted -4- methyl -5- oxo triazolo quinazolines.

28. Evaluation of anti asthmatic activity of curculigo orchioides rhizomes.

29. Synthesis and pharmacological investigation of novel 4-(3-ethyl phenyl)1- substituted 4H

(1,2,4) triazolo (4,3-A) quinazolin-5-ones as a new class of antihistaminic agents

30. Invitro antibacterial activity of ten series of substituted quinazolines.

31. Synthesis, antiviral and cytotoxic activities of some novel 2-phenyl 3 disubstituted

quinazolin 4 ones.

32. Synthesis, characterization and in vitro antifungal evaluation of novel benzimidazolo

quinazolines

23

33. Synthesis of some new quinazoline analogs and their antimicrobial activity.

34. Synthesis of some new quinazolin 4 one derivatives and evaluation of their antimicrobial

and anti-inflammatory effects.

35. Analysis of heavy metals in waterm sediments and fish samples of madivala lakes of

Bangalore.

36. Antiinflammaorty and analgesic activity of Balanites aegyptiaca in experimental animal

models.

37. Antimicrobial activity of blue green anad green algae

38. HPLC studies on the targeting efficiency of etoposide immune conjugates on EAC

induced cancer in mice.

39. Development and evaluation of hepatitis B antigen loaded PLGA microspheres for single

shot vaccination.

40. Community pharmacists as a medican in 2020.

41. Overview of clinical data management

42. Contribution of medical wastes to the total pollution level in jaunpur city

43. Awareness of pharmacy students regarding self medication

44. Role of clinical pharmacist in health care management.

45. First pass effects of verapamil on the intestinal absorption and liver disposition of

fexofenadine in the porcine model.

46. Inhibitor like activity in rat cerebrospinal fluid after stimulation by an aversive quinine

taste.

47. Rice based mucosal vaccine as a global strategy for cold chain and needle free

vaccination.

48. AIDS vaccine: present status and future challenges

49. Dental caries vaccine

50. In vivo evaluation of single dose tetanus toxoid vaccine formulation with chitosan

microspheres.

51. Rotavirus vaccines

52. Quadrivalent human papillopmavirus recombinant vaccine: the first vaccine for cervical

cancers

CIMAP GOLDEN JUBILEE NATIONAL SYMPOSIUM ON FUTURE TRENDS IN

MEDICINAL AND AROMATIC PLANTS TECHNOLOGIES AND STRATEGIES. 17TH

NOV 2009.

53. Isoquinoline alkaloids as pro-antioxidant and 12-LOX inhibitor im mahonia aquifolium

extract.

54. Antibacterial and wound healing activity of roots of Sesamum indicum.

55. Anti-inflammatory activity of Delonix elata.

1st NATIONAL LEVEL SEMINAR DRAVYAKA 2010, 19 20 TH MARCH 2010 AT GEETHANJALI COLLEGE OF PHARMACY, HYDERABAD.

24

56. High performance liquid chromatography method for determination of diltiazem human

plasma.

APTICON-2010

57. Solid liquid nano particles containing nimesulide preparation, characterization and

cytotoxic studies.

58. Synthesis, characterization and antifungal activity of novel quinoline -4-one derivatives

containing 8-hydroxyl quinazoline liquid and its various metals complexes.

59. Synthesis and antimicrobial activity of quinoxaline based thiazolidines and azetidinones.

60. Synthesis, characterization and biological activity of various substituted benzothiazole

derivatives.

61. Anti-inflammatory activity of flowers of tabemarementana diresicata linn.

62. Development and validation of RP-HPLC method for the determination of adefair

dipivoxil in bulk and its pharmaceutical formulation

63. Optimisation of alkaline protease production from a mutant of alkalophylic bacillus

pantotheneticus using molasses a substrate.

ICODD THEME: EMERGING INNOVATIONS IN DRUG DELIVERY TECHNOLOGY 29-

30TH JANUARY 2010.

64. Formulation design of fast dissolving tablets of clonazepam by sublimation method.

65. Formulation and development of fast dissolving tablets contain solid dispersions of

felodipine.

66. Formulation and release studies of nimusulide solid dispersions.

67. Enhancement of dissolution rate of amperozide using solid dispersions with polyethylene

glycol.

68. Poly nanaoparticle based inhalable sustained drug delivery system for experimental

tuberculosis.

69. Simultaneous RP-HPLC determination of nimesulide and paracetamol in tablets

70. Respiratory tract drug delivery newer approaches for drug delivery to and via respiratory

tract.

NATIONAL SEMINAR ON REVENT ADVANCES IN ANALYTICAL SCIENCES INDIAN

PERSPECTIVE (RASSI) AT IICT, HYDERABAD 20,21ST –JAN 2011.

71. 31PNMR spectroscopy detects metabolic abnormalities in asymptomatic patients with

cardiac myopathy.

72. LC/MS analysis of N-terminal protein adducts with improved sensitivity. A comparison

of selected edman iso thiocynathate reagents.

73. A validated RP HPLC –PAD method for the determination of hedercoside with in

hivythyme cough syrup

74. New spectrophotomeric and fluorimetric methods for determination of fluoxetine in

pharmaceutical formulations

25

75. HPLC and anti-inflammatory studies of the flavanoid rich chloroform extract fraction of

Orthosiphon stamineus leaves.

76. HPLC, NMR and MALDI-TOF MS analysis of condensed tannins form Lithocarpus

glaber leaves with potential free radical scavenging activity.

TWO DAY NATIONAL CONFRENCE ON REFORMS AND INNOVATIONS IN

PHARMACY EDUCATION IJAPR ON 17-18 AUG 2012.

1. Non Erodible

Polymericmatrix Tablets Of Isoniazid Using Sintering Technique: Design And Invitro

Evaluation Of Matrix Tablet

2. Extended

Release Metformin Hydrochloride From Hydroxy Propyl Methyl Cellulose Matrices

Formulation And In Vitro - In Vivo Evaluation

3. Formulation Of

Sustained Release Ranitidine Tablets

4. Synthesis And

Antimycobacterial, Photosynthesis-Inhibiting, And Antialgal Activity Of Quinazoline-4-

Thiones

5. Microwaves for

Sol-Gel Synthesis Of Boron Carbide.

6. Conventional

And Microwave Assisted Synthesis And Qsar Studies Of Coumarinylchalcone Analogs

As Potent Antimicrobial Agents.

7. Lc-Ms/Ms Determination Of Bromperidol In Biological Matrices: Method Validation

And Forensic Application.

8. Design and invitro evaluation of colon targeted oral matrix tablets of Mesalamine for the treatment of inflammatory bowel diseases.

DRAVYAKA-2012 ON 15-14TH APRIL AT GITNJALI COLLEGE OF PHARMACY,

HYDERABAD.

77. Extra nuclear effects of thyroid hormones in skeletal muscle.

78. New targeted therapies for anaplastic thyroid cancer.

79. Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons

from the recent clinical trials.

80. Therapeutic agents for alzheimer‟s disease.

81. Vinyl sulfoe containing parasitic cysteinyl protease inhibitors

82. Natural products: promising resources for cancer drug discovery

83. Targeting cancer using fragment based drug discovery

84. A QSAR study on some series of HIV -1 integrase inhibitors

85. Aspartate aminotransferase –bridging carbohydrate and energy metabolism in

plasmodium falciparum

86. Design, synthesis and antitumor activity of novel D-glucoronic acid derivatives

87. LC-MS/MS determination of bromperidol in biological matrices: method validation and

forensic application

26

88. Oxygen free radicals and their biomedical implications: A mini review

a. Potential anticancer properties of bisphosphonates : insights from preclinical

studies

89. Recent advances in the development of small molecule compounds targeting HIV-1 as

membrane fusion inhibitors

90. Synthesis,antimicrobial and anti inflammatory evaluation of substituted 1,2,4 triazole

analogs

91. Application of HPTLC and LC_MS methods of determination of topiramide in

pharmaceutical formulations

92. Methods for analysis of free radicals in cigarette smoke

93. Cancer nanotechnology: emerging role of gold nanoconjugates.

PHARMACONVENTION 2012 AT PADMAVATHI SCHOOL OF PHARMACY,

THIRUPATHI, A.P

94. Design of Rivastigmine based on molecular docking and binding free energy calculation.

CPER CURRENT STATUS AND FUTURE PROSPECTS IN PHARMACY EDUCATION

AND RESEARCH TOWARDS INDUSTRY APPLICATION 29-30TH NOV 2013.

95. Availability And Dispensing Practices For Antimalarials And Antimicrobials In Western

Kenyan Pharmacies

96. Non-Equivalence Of Antibiotic Generic Drugs And Risk For Intensive Care Patients.

97. Hold Time Stability Studies In Pharmaceutical Industry: Review

98. A planning model of pharmaceutical needs for mass gatherings at public special events.

99. The Development Of Intellectual Property Policies In Africa- Some Key

Considerations And A Research Agenda

100. Contribution of web for the research on pharmaceutical patents

101. Evaluation of the Learning Environment at the Faculty of Medicine, Suez Canal

University: Students? Perceptions

102. Growing Conflicts between Intellectual Property Rights and Health.

CMR COLLEGE OF PHARMACY, PHARMA INNOVATE 2K13. 27-28 DEC 2013.

103. Gastroprotective Activity of Plant Belongiing To Chrozophora Species.

104. Screening Of Skeletal Muscle Relaxant Activity Of Plant Vicia Faba

105. Procedure for drug approval in different coutries

106. Regulatory environment and clinical trials in south east asia.

107. A novel approach of fast dissolving oral films: a review

108. The role of regulatory GMP audit in pharmaceutical companies

109. Design and in vitro evaluation of gastroprotective valacyclovir HCL floating tablets

27

110. ANDA paragraph IV filings: a complete review

111. The common technical document: taking Indian NDA process towards globalization

112. Formulation and in vitro evaluation of fast disintegrating tablets of elitriptan HCL.

APTICON- 2013.

113. Legal protection of intellectual property : the changing attitude of US and its

influence on Taiwan.

114. Formulation development and evaluation of sustained release pellets of tramadol

HCL

115. The cumulative protection of designs in the European union and the role in such

protection of copyrights

116. PAY „n‟ PLAY : public performance of sound recordings VIS-À-VIS copyright

infringement.

117. PRESENTED A POSTER IN NATIONAL LEVEL SYMPOSIUM ON EMERGING

CHALLENGES AND TRENDS IN PHARMACY PROFESSION IN FUTURE AHEAD

HELD AT AVANTHI INSTITUTE OF PHARMACEUTICAL SCIENCES ON 8TH

APRIL 2013.

INDIAN COUNCIL OF MEDICINAL RESEARCH AND JSS UNIVERSITY, MYSORE. Sponsored TWO DAYS NATIONAL SEMINAR ON COMPUTER AIDED DRUG DESIGN

DISCOVERY OF NEW MOLECULES. (16th and 17th August 2013).

118. Synthesis and SAR studies of Praziquantel derivatives with activity against

schistoma japonicum.

119. A reassessment on quinazoline -2,4 (1H,3H)-dione as a substitute for thymine in

triple helix forming oligonucleotides.

120. Holographic quantitative strucuture activity relationship of tryptamine derivatives

at NMDA, 5HT 1A and 5HT 2A receptors.

121. Panduratin A, a possible inhibitor in metastasized A549 cells through inhibition of

NF-Kappa B translocation and chemoinvasio.

NATIONAL CONFERENCE ON EMERGING OPPURTUNITES OF CLINICAL TRIALS IN

HOSPITAL INDUSTRY. ROLE OF PHARMACIST IN ENSURING REGULATORY

COMPETANCE. NATIONAL CONFERENCE HELD AT MALLA REDDY MEDICAL

COLLEGE FOR WOMEN. HYDERABAD ON 1ST AND 2ND AUGUST 2014.

122. Nanogel-Based Delivery Of Mycophenolic Acid Meliorates Systemic Lupus

Erythematosus In Mice

28

123. Nano-Medicine Based Drug Delivery System

124. R-Dna Technology-Case Study

NATIONAL SYMPOSIUM ON CURRENT TRENDS IN PHARMACEUTICAL SCIENCES

ON 1ST MARCH 2014 BY ANWARUL ULOOM COLLEGE OF PHARMACY, NEW

MALLEPALLY, HYDERABAD.

125. Development & Evaluation Of Bilayer Floating Bioadhesive Tablets Of Repaglinide And Glipizide

126. Formulation Development And Evaluation Of Sustained Release Pellets Of

Tramadol Hydrochloride

127. Procedure For Drug Approval In Different Countries

128. Pharmaceutical Regulatory Affairs – Review

129. Regulatory & Patent Laws Of Drug Design, Safety And Environmental Aspects

Of G8 Countries

130. Gastroprotective Activity Of Celosia Argentea Leaf Against Stress Induced

Ulcers In Rats

131. Comparitive Profiles Of Neuromuscular Blocking Properties Of Leaves And

Seeds Of Plant Vicia Faba

132. Development And Validation Of Uv-Spectrophotometric Method For

Determination Of Torsemide In Tablet Dosage Form

Guidance Detail

M.PHARM THESIS

PHMNRA - MPHARM- PHARM MANG AND REGULATORY AFFAIRS-2012

S. NO H.T.NO NAME OF THE STUDENT CONTACT NUMBER

1

12Y61S1001

K NARESH

REGULATORY

REQUIREMENTS

FOR

PHARMACEUTICAL

PRODUCT

REGISTRATION IN

INDIA. 2014

2

12Y61S1002

K CHAITANYA PRASAD

NEW DRUG

APPLICATION (NDA)

APPROVAL AND

APPROVED DRUGS

OF FDA FROM 2010

TO 2013,

2014

29

3

12Y61S1003

DEVARAKONDA AJAY KUMAR

DRUG

DESIGN,MANUFACT

URING AND TOTAL

QUALITY CONTROL

MANAGEMENT OF

USA & INDIA 2014

4

12Y61S1004

KOLLURI SRINATH

. NDA DRUG

APPROVAL PROCESS

SINCE 2010 AND

DMF,DOSSIER OF

USF DA, 2014

5

12Y61S1005

BACHU SNIGDA

REGULATORY AND

INTELLENCTUAL

PROPERTY RIGHTS

DOCUMENTATION

IN INDIA & USA, 2014

6

12Y61S1006

KAYITHOJ SANTHOSH KUMAR

. COMPARISION OF KEY REQUIREMENTS

FOR THE REGISTRATION OF

GENERIC INJECTABLES IN

LATAM,BRAZIL&ME XICA, 2014

7

12Y61S1007

NYALAM AJUTESH BABU

NEW DRUG

APPROVAL PROCESS

OF E.U.JAPAN & COREA, 2014

8

12Y61S1008

KATIKANENI SHRAVYA

REGULATORY

DOSSIERS OF ASEM

COUNTRIES, 2014

9

12Y61S1009

AMANAGANTI KRANTHI KUMAR

IND & NDA DRUG

APPROVAL

PROCESS IN UNITED

STATES OF AMERICA

AND EUROPEAN

UNION, 2014

10

12Y61S1010

DEVAMADA SREEKANTH

REGULATORY

ASPECTS OF

PRECLINICAL

.CLINICAL &

PHARMACOVIGILAN

CE OF BRICS (BRAZIL,RUSSIA,IND

30

IA,CHINA,SOUTH

AFRICA)& USA. 2014

11

12Y61S1011

POLANGARI SWATHI

. REGULATION OF

PRECLINICAL

&CLINICAL TRIAL

APPROVAL PROCESS

IN ASEAN

COUNTRIES. 2014

12

12Y61S1012

B VARA PRASAD RAO

REGULATORY REQUIREMENTS FOR

GENERIC DRUG DEVELOPMENT IN

USA&EMEA MARKET, 2014

13

12Y61S1013

GONE SRIKANTH

IPR AND

REGULATORY

DOSSIER OF USA,

2014

14

12Y61S1014

SAMULA SAMATHA

ICH GUIDELINES &

DRUG APPROVAL

PROCESS OF SAARC COUNTRIES. 2014

15

12Y61S1015

M.PRABHODH

REGULATORY

AUDITS AND IPR

INSPECTIONS OF D8

COUNTRIES, 2014

16

12Y61S1016

MOHD VASEEVUR RAHMAN

COMPARITIVE

STUDY OF IPR IN

SAARC COUNTRIES

(INDIA,BANGLADES

H,BHUTAN,NEPAL,S

RILANKA,AFGHANIS

THAN,PAKISTHAN),

2014

17

12Y61S1017

ASHISH RAJENDRA KUMAR

REGULATORY AND

DOSSIER APPROVAL

PROCESS OF TOP 10

COMPANNIES IN

GLOBAL LEVEL, 2014

18

12Y61S1018

D.RASTRAPAL

REGULATORY &

PATENT LAWS OF

DRUG DESIGS &

SAFATY ,

31

ENVIRONMENTAL

ASPECTS OF G8

COUNTRIES. 2014

19

12Y61S1019

G.DILIP KUMAR

REGULATORY

LAWS,AUDITS,LITIG

ATIONS AND RISK

MANAGEMENT OF

G20 COUNTRIES. 2014

20

12Y61S1020

N.ASHOK KUMAR

REGULATORY

SYSTEMS AND

DOCUMENTATION

IN BRICS COUNTRIES

, QUALITY

ASSURANCE,PROCES

S VALIDATION AND

PHARMACOVIGILAN

CE STUDIES. 2014

PAQA

21

11Y61S0401

SHILPA EDUNOORU

Analytical Method

Development And

Validation Of

Indapamide And

Perindopril Erbumine

By

RP-HPLC Method In

Bulk And Tablet Dosage

Forms. 2013

22

11Y61S0416

N.CHIRANJEEVI

Bioanalytical Method

Development And

Validation For

Estimation Of Irbesartan

In Human Plasma Using

Irbesartan D4 Internal

Standard By Liquid

Chromatography And

Tandem Mass

Spectrometry Method, 2013

23

11Y61S0417

D.NARESH

RP-HPLC Method

development

and Validation for the

simultaneous

quantitative estimation

of Zolpidem Tartarate

32

and Melatonin in Tablets. 2013

24

12AD1S0401

G.MOUNIKA

METHOD

DEVELOPMENT AND

VALIDATION OF

CLOMIPRAMINATE

HYDROCHLORIDE

FLUVOXAMINE BY RP-HPLC METHOD

25

12AD1S0413

R.R.BANGARAMMA

METHOD

DEVELOPMENT AND

VALIDATION OF

SIMULTANEOUS

ESTIMATION OF

SAXAGLIPTIN AND

METFORMIN BY RP-

HPLC IN BULK AND

COMBINED DOSAGE FORMS

26

12AD1S0414

R.SRAVANI

A VALIDATED RP-

HPLC METHOD FOR

SIMULTANEOUS

ESTIMATION OF

HYDROCHLOROTHIA

ZIDE AND

QUINAPRIL

HYDROCHLORIDE IN

ITS BULCK AND

PHARMACEUTICAL

DOSAGE FORM

27

12AD1S0415

S.NAGA CHANDRIKA

A VALIDATED RP-

HPLC METHOD FOR SIMULTANEOUS

ESTIMATION OF FLUOXETINE

HYDROCHLORIDE AND OLANZAPINE IN

TABLETS

Pharmaceutical Chemistry

33

28

10AD1SO201

K.Balaraju

Method validation for

related substances in

telemistran in

telemistran tablets by

using RP-HPLC method,

2012

29

10AD1SO206

Pallavi vedire

Antidiabetic activity of

leaf extract of gymnema sylvestre in rats and

molecular docking of its gymnemic acid on

eNOS in diabetic humans, 2012

30

10AD1SO207

Rajendra Prasad.N

Molecular docking and

QSAR Studies of

Various phytochemicals

as drug targets against

lactate dehydrogenase of

plasmodium falciparum

in the treatment of

malaria

31

10AD1SO208

Raheem Pasha sheik

Phytochemicals of

Barleria cristata AND

Butea monosperrma AS

DRUG AGAINST

ASPARAGENYL t –RNA

SYNTHETASE Brugiya

malayi : AN IN –

SILICO APPROACH

32

10AD1SO209

Saritha devi N

METHOD

VALIDATION OF

VALACYCLOVIR

HYDROCHLORIDE

BY RP-HPLC-PDA METHOD

33

0406105

C.RATNAMANI

SYNTHESIS,

ANTIMICROBIAL

AND ANTI-

INFLAMMATORY

ACTIVITY OF 3-(2-

(17Z)-5-

SUBSTITUTED) -4‟- OXO -2‟-PHENYL,

34

IMIDAZOL-1‟-YL)-2-

SUBSTITUTED

METYL

/ARYL/CHLOROMET

HYL QUINAZOLIN-

4(3H)-ONES

34

04-05-102

K.BHAGYA LAXMI

CHEMICAL

INVESTIGATION OF

BOSWELLIA

SERRATA ROXB AND

PHOSPHOMOLYBDIC

ACID

(H3PMO12O4

0) CATALYSED SYSTHESIS OF

HANTZSCH 1,4-

DIHYDROPYRIDINES

AND β –ENAMINO

COMPOUNDS

35

10AD1SO101

T.ANITHA REDDY

EVALUTION OF

ANTI-

OXIDANT,ANALGESI

C AND ANTI-

INFLAMMTORY

ACTIVITIES OF A

HERBAL FORMULATION

36

11AD1S0201

G.AKILA

Synthesis,

Characterization and

Biological Evaluation of

Novel Pyrazoline

derivatives.

37

12AD1S0203

YEDLA RAJESHWARI

“Reverse vaccinology

approach for designing

vaccine against

syphilis”

38

12AD1SO416

NIHARIKA SRIDASAM

Analytical Method

Development and

Validation of

Bendamustine

Hydrochloride by RP-

HPLC in API and

Pharmaceutical Dosage

Forms

39 12AD1S0408 M.DIVYA “SIMULTANEOUS

35

ESTIMATION OF

SERTRALINE AND

ALPRAZOLAM IN ITS

BULK AND

PHARMACEUTICAL

DOSAGE FORM BY

RP-HPLC METHOD”

40

12AD1S0108

K.SHALINI

WOUND HEALING

ACTIVITY OF

METHANOLIC

EXTRACT OF

LEAVES OF

PEDALIUM MUREX IN

VARIOUS MODELS

HTNO PROJECT THESIS TITLE

15Y61S0410 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION

OF ALISKIREN AND AMLODIPINE

15Y61S0302 COMPARISON OF EFFECT OF NATURAL AND SYNTHETIC POLYMERS ON IN VITRO DRUG

RELEASE IN FORMULATION OF CONTROLLED RELEASED BY USING ATOMOXETINE HCL

15Y66S0302 FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF GASTRORETENTIVE

DRUG DELIVERY OF TRAMADOL HYDROCHLORIDE

15Y66S0301 FORMULATION AND EVALUATION OF FAST DISSOLVING ORAL FILMS OF

RIZATRIPTAN BENZOATE

15Y61S0305 FORMULATION AND INVITRO EVALUATION OF LAMOTRIGINE

36


ORAL THIN FILMS

15Y61S1023 Product registration strategies, Patent filing to India, USA. Current Appraisal Procedure for

New drug regulation standards and guidelines issued by regulatory authorities by India, USA & EU

15Y61S1002 COMMERCIALASPECTSOFREGULATORYAPPROVALSAND REGULATIONSING8COUNTRIES

15Y66S0308 PREPARATION AND IN VITRO CHARACTERISATION URAPIDIL

FAST DISSOLVING TABLETS USING SOLID DISPERSION TECHNIQUE

15Y66S0310 FORMULATION DEVELOPMENT AND INVITRO EVALUATION OF FLOATING

DRUG DELIVERY OF GLIBENCLAMIDE

15Y66S0316 FORMULATION AND IN VITRO EVALUATION OF SUSTAINED RELEASE

MATRIX TABLETS OF MEBEVERINE BY USING NATURAL POLYMERS

15Y61S0301 FORMULATION AND EVALUATION OF NIZATIDINE FLOATING TABLETS

15Y61S0402 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF NEVIRAPINE

IN BULK AND TABLET FORMULATION

15Y61S0409 METHOD DEVELOPMENT AND VALIDATION FOR SIMULTANEOUS ESTIMATION

OF LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE IN PHARMACEUTICAL

FORMULATION AND BIORELEVANT DISSOLUTION MEDIA BY CHROMATOGRAPHIC TEC

37


15Y66S0404 METHOD DEVELOPMENT AND VALIDATION OF IMATINIB MESYLATE BY RPHPLC

15Y66S0309 DESIGN AND EVALUATION OF NARATRIPTAN DISPERSABLE TABLETS

15Y66S0411 RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS

ESTIMATION OF CETIRIZINE AND PSEUDOEPHEDRINE

16Y61S0403

A Novel Method for

Chromatographic Determination of

Ciprofloxacin and Metronidazole in

Pure Form and Formulation by

Using RP-HPLC

16Y61S1020

CHALLENGES OF DRUG

REGULATORY SUBMISSION IN

INDIA AND REGULATIONS ON

LABELLING AND

ADVERTISMENTS

16Y61S1011

Approval, Manufacture and

Marketing Regulations of Medical

Devices in Regulated Markets

USFDA, European Union, India

16Y61S1022

REGULATORY REQUIREMENTS

FOR SUBMISSION AND

COMPILATION OF DOSSIER

FOR PRESCRIPTION

MEDICINES (PARENTERALS) IN

AUSTRALIA-TGA

16Y61S1018

REGULATIONS - OF - NARCOTIC

- DRUGS

16Y61S0401

SIMPLE AND SENSITIVE

ANALYTICAL METHOD

DEVELOPMENT AND

VALIDATION OF LAMIVUDINE

38

AND NEVIRAPINE BY RP-HPLC

16Y66S0415

ANALYTICAL METHOD

DEVELOPMENT AND

VALIDATION FOR THE

ESTIMATION OF

DAPAGLIFLOZIN AND

METFORMIN BY RP-HPLC

16Y61S0410

RP HPLC METHOD

DEVELOPMENT AND

VALIDATION OF

BICAULTAMIDE AND

ATENOLOL IN ITS PURE

DOSAGE FORMS

16Y66S0406

ANALYTICAL METHOD

DEVELOPMENT AND

VALIDATION FOR THE

SIMULTANEOUS ESTIMATION

OF ACYCLOVIR AND

VALACYCLOVIRBY RPHPLC

METHOD

16Y66S0410

ANALYTICAL METHOD

DEVELOPMENT AND

VALIDATION OF GEMICTABINE

AND CLARITHROMYCIN IN

COMBINED DOSAGE FORM BY

RP-HPLC

16Y66S0419

A PROSPECTIVE VALIDATION

OF BISOPROLOL FUMERATE

AND HYDROCHLOROTHIAZIDE

IN ITS PURE AND BULK DOSAGE

FORMS BY USING RP HPLC

TECHNIQUE

16Y66S0409

METHOD DEVELOPMENT AND

VALIDATION OF

GILCOPYRROLATE AND

FORMOTEROL FUMERATE BY

_DB

16Y66S0417

ANALYTICAL METHOD

DEVELOPMENT AND

VALIDATION FOR


OF AMLODIPINE AND

BENAZEPRIL IN

PHARMACEUTICAL DOSAGE

39

16Y61S1001

REGULATORY ISSUES OF

IMPORT OF PHARMACEUTICAL

PRODUCTS IN USA AND

CANADA

16Y61S1019

COMMERCIAL ASPECTS OF

REGULATORY APPROVALS

AND REGULATIONS UNDER

BRICS

16Y61S1004

HERBAL MEDICINE: A

GROWING FIELD WITH A LONG

TRADITION

16Y61S1003

LATEST TRENDS IN ARCHIVING

OF REGULATORY SUBMISSION

16Y61S1005

ADVERSE EVENT REPORTING

REQUIREMENTS IND AND POST

MARKETING

16Y61S1008

AN ANALYSIS OF FDA RECENT

DRUG GMP WARNING LETTERS

16Y61S0408

NOVEL HPLC METHOD FOR

SIMULTANEOUS ESTIATION OF

DOXYLAMINE AND

PYRIDOXINE IN BULK AND

COMBINEDDOSAGE FORM

16Y66S0418

A NEW METHOD

DEVELOPMENT BY RP HPLC

METHOD FOR

CANAGLAFLOZIN

16Y61S0407

A NEW METHOD

DEVELOPMENT AND

VALIDATION OF

SULFAMETHOXAZOLE AND

TRIMETHOPRIM IN ITS PURE

AND PHARMACEUTICAL

DOSAGE FORM

16Y61S1010

CURRENT TRENDS IN REVIEW

OF CTD DOSSIER

16Y61S0405

A NEW RP-HPLC METHOD

DEVELOPMENT AND

VALIDATION FOR


OF DICYCLOVERINE AND

40

TRAMADOL IN ITS PURE AND


FORMS”

16Y66S0408

A NEW VALIDATED RP-HPLC

METHOD FOR

DETERMINATION OF

CIPROFLOXACIN AND

ORNIDAZOLE IN BULK


FORMS

16Y61S0414

ANALYTICAL METHOD

DEVELOPMENT AND

VALIDATION FOR THE


OF HYDROCHLORTHIAZIDE

AND RESERPINE BY USING RP-

HPLC TECHNIQUE

16Y66S0413

ANALYTICAL-METHOD-

DEVELOPMENT-AND-

VALIDATION-FOR-

IVERMECTIN-AND-

ALBENDAZOLE-IN-COMBINE-

DOSAGE-FORM- BY-RP-HPLC

16Y61S0409

ANAYTICAL METHOD

DEVELOPMENT AND

VALIDATION FOR THE


OF METFORMIN AND

ALOGLIPTIN BY RP-HPLC

METHOD

16Y61S0413

ANALYTICAL METHOD

DEVELOPMENT AND

VALIDATION OF PIPERAQUINE

TETRAPHOSPHATE AND

DIHYDROARTEMISININ IN

COMBINE DOSAGE FORMS

16Y61S1016

INTER RELATIONSHIP

BETWEEN RA, QA, QC FOR

REGULATORY SUBMISSION

16Y61S1012

CURRENT REGULATION FOR

VARIATION FILINGS FOR THE

REGISTERED PRODUCTS

16Y66S0407 A NEW VALIDATED RP-HPLC

41

METHOD FOR

DETERMINATION OF

ROSUVASTAIN AND

TELMISARTAN IN BULK AND


FORM

16Y61S0406

A NEW METHOD

DEVELOPMENT AND

VALIDATION OF

AZITHROMCYCIN AND

CEFIXIME IN ITS PURE AND


FORM

16Y66S0412

A NOVEL RP-HPLC METHOD

FOR DEVELOPMENT AND

VALIDATION OF

SIMULTANEOUSLY

ASSESSMENT OF MECLIZINE

HYDROCHLORIDE AND

PYRIDOXINE

16Y66S0402

NOVEL RP-HPLC METHOD

DEVELOPMENT AND

VALIDATION FOR ESTIATION

OF CYTARABINE IN BULK AND

COMBINEDDOSAGE FORM

16Y66S0403

“.A NEW VALIDATED RP-HPLC

METHOD FOR ESTIMATION OF

AMBROXOL AND AMOXICILLIN

IN BULK AND


FORMS

16Y61S0416

SIMPLE AND SENSITIVE

ANALYTICAL METHOD

DEVELOPMENT AND

VALIDATION OF

NITAZOXANIDE AND

OFLOXACIN BY RP-HPLC

16Y61S0412

DEVELOPMENT AND

VALIDATION OF HIGH

PERFORMANCE LIQUID

CHROMATOGRAPHY METHOD

FOR THE DETERMINATION OF

DICYCLOMINE AND

CHLORIDAZEPOXIDE IN


42

FORM

16Y61S0301

FORMULATION AND

EVALUATION OF RAPID ON SET

MOUTH DISSOLVING FILM

16Y61S0317

FORMULATION DEVELOPMENT

AND INVITRO EVALUATION OF

ARIPIPRAZOLE

ORODISPERSIBLE TABLETS

16Y61S1009

CURRENT TRENDS IN

REGULATORY PROJECT

MANAGEMENT AND DRUG

APPROVALS IN USA

16Y61S1015

EV¿LU¿T¿¿N ¿F ¿MPL¿C¿T¿¿NS

¿F ¿MPLEMENT¿T¿¿N ¿F

QU¿L¿TY BY DES¿GN ¿N

PH¿RM¿CEUT¿C¿L

PR¿CESS¿NG.

16Y61S1017

Challenges in regulatory filings for

generic products

16Y61S1023

C¿MPARATIV¿ G¿N¿RIC DRUG

SUBMISSI¿N PR¿C¿DUR¿ F¿R US

& ¿UR¿P¿ MARK¿T

16Y61S1024

MARKETING AUTHORIZATION

OF NEW DRUGS IN EUROPE

AND USA

PhD

SUBJECTS HANDLED & HANDING

Adv.Instrumental Analysis Adv.

Medicinal Chemistry Adv. Natural Chemistry

Adv .Organic Chemistry Pharmacoinformatics

Patent & Intellectual Property Rights and Forensic Pharmacy

Environmental Chemistry

SKILLS & FIELDS OF SPECIAL INTEREST

Extraction of Phyto-Constituents

Isolation Techniques, Chromatographic Techniques

Interpretation of compounds, HPLC, LC-MS,NMR, IR

43

Tissue Culture, Handling of Animals

PERSONAL DETAILS

First name Suthakaran

Last name Raj

Sex Male

Date of Birth 04-06-1975

Nationality Indian

References

1) Dr. T.V. Narayana, Director & Principal

President, IPA

Vikas Institute of Pharmaceutical Sciences

Nidigatla Village, Korukonda Mandal, Near Airport

Rajahmundry, E.G. Dist, Andhra Pradesh - 533103

Ph. No. (0883) 2007843, Fax : 244102

+91 98450 20474,

E-mail : [email protected]

2) S.Kavimani M.Pharm.,PhD

Professor and HOD

Department of Pharmacology

College of Pharmacy

Mother therasa Post graduate Institute of Health Sciences

Puducherry-605006, India, Mobile: +919443085956

3) Dr.M.Bhagavan Raju M.Pharm.,PhD,

Professor and Principal

Department of Pharm. Chemistry

C.M College of Pharmacy

Malla Reddy group of institutions

Medchal, Hyderabad, Andhra Pradesh, India. Mobile:09348161227

DECLARATION

I hereby declare that the information furnished above are true and correct to the best of my

knowledge and belief.

mailto:[email protected]

44

Place : Hyderabad

Date : 17/03/2018

[Dr. R.Suthakaran]

Curriculum Vitae€¦ · (IPER), Pune, Maharastra, India. Institute of Pharmaceutical Education...

Documents

Transcript of Curriculum Vitae€¦ · (IPER), Pune, Maharastra, India. Institute of Pharmaceutical Education...